loader
Please Wait
Applying Filters...
menu
    • menu

    List of Written Confirmation(s) issued for methyl 2-phenyl-2-piperidin-2-ylacetate hydrochloride Active Pharmaceutical Ingredient (API)

    Client Email Product
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    methyl 2-phenyl-2-piperidin-2-ylacetate;hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 783Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    22/04/2020 Cohance Lifesciences
    India
    		 M/s. ZCL Chemicals Limited WC-0195 Methylphenidate Hydrochloride EP/USP 2022-08-25 2025-07-02 Plot No. 3102/B, GIDC, Industrial Estate, Ankleshwar-393 002, Bharuch, Gujarat India
    06/08/2020 Harman Finochem
    India
    		 M/s. Harman Finochem Ltd., WC-0045 Methyl Phenidate Hydrochloride (EP/USP) 2022-06-08 2025-07-21 Plot No. E-7, 8, 9 MIDC, Industrial Area, Chikalthana, Aurangabad Maharashtra India